Last Updated on July 15, 2021 by The Health Master
“The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September,” RDIF said in a statement.
The parties intend to produce over 300 million doses of the vaccine in India per year, it added.
“As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun,” RDIF said.